Close
Back to mobile site

BOLD Financial Facts

See Full Income Statement

See Full Balance Sheet

Audentes Therapeutics (BOLD) Earnings

  |   Expand Research on BOLD
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -2.2% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +1.7% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/7/19 Q319 -$1.00-$1.07 +$0.07N/AN/A N/A Details
8/6/19 Q219 -$1.01-$1.04 +$0.03N/AN/A N/A Details
5/7/19 Q119 -$1.13-$0.89 -$0.24N/AN/A N/A Details
2/27/19 Q418 -$0.84-$0.92 +$0.08N/AN/A N/A Details
11/6/18 Q318 -$0.97-$0.88 -$0.09N/AN/A N/A Details
8/7/18 Q218 -$0.85-$0.78 -$0.07N/AN/A N/A Details
5/9/18 Q118 -$0.74-$0.80 +$0.06N/AN/A = Details
3/8/18 Q417 -$0.82-$0.91 +$0.09N/AN/A = Details